Cyclosporin A (CsA) is a potent immunosuppressant widely used in human medicine to prevent rejection of transplanted organs. Total concentration of CsA and its metabolites in human blood was determined by pyrolysis mass spectrometry (pyr-ms). Mass to charge (m/z) values of 100 of CsA and 3-nitroaniline as an internal standard were used for quantitative measurements by selected ion monitoring (SIM). Results of pyr-ms at 420˚C are highly reproducible. Limit of detection (LOD) and linearity were determined to 0.7 ng ml -1 and 0.7 ng ml -1 -100 mg ml -1 , respectively. LOD is improved to 0.02 ng ml -1 by using a solid phase extraction (SPE) disk. Results of pyr-ms are compared with those obtained by the high performance liquid chromatography (HPLC) measurements.
Keywords Pyrolysis mass spectrometry, Cyclosporin A, solid phase extraction tion of CsA and its metabolites, such as radioassay (RIA) kits. These methods also suffer from limited stability and low sensitivity. [6] [7] [8] [9] [10] [11] Up to now, the contribution of mass spectrometry to CsA research has been based on the determination of molecular mass, type of amino acids substitutions and sequencing. [12] [13] [14] [15] [16] On the other hand, pyrolysis or controlled thermal fragmentation has been used and developed to elucidate peptide structures and concentrations. [17] [18] [19] [20] In this work, we present a method based on the combination of pyrolysis and mass spectrometry techniques for the determination of the total concentration of CsA and its metabolites in blood. The SIM methods with m/z 100 of N-methylleucine (MeLeu) and 3-nitroaniline as an internal standard were used. The optimized temperature for pyrolysis was found to be 420˚C. The LOD and linearity were found to be 0.7 ng ml -1 and 0.7 ng ml -1 -100 mg ml -1 , respectively. LOD can be improved even further to 0.02 ng ml -1 by use of SPE disks. Results are compared with those of HPLC measurements. Our results indicate that pyr-ms have better reproducibility, sensitivity, LOD and linearity than previous methods.
Experimental

Reagent and chemicals
HPLC grade methanol and acetonitrile were obtained from Fluka (Switzerland). All cyclosporins standard were obtained from Galena (Czech Republic). 3-Nitroaniline was supplied by Merck (Germany). The C 18 disk of Varian Co. (No. 1214-5004) was used for the extraction.
Apparatus
All mass spectra were recorded by VG instrument model Trio 1000. The ion source was operated at 70 eV under a pressure of 4×10 -4 bars and a temperature of 250˚C. The liquid chromatography system was Shimadzu Model 6A. Blood samples were measured by an isocratic system using Water C 18 column. The composition of the mobile phase were 70% acetonitrile/water v/v. The column temperature were maintained at 70˚C. The flow rate and wavelength were set at 1 ml/min and 210 nm respectively.
Procedure
Blood samples from ten transplant patients receiving CsA were obtained from Shariety hospital Tehran. One milliliter of blood was placed in a 20 ml test tube and a 500 ng of the internal standard was added. The sample was vortexed for 3 min and centrifuged for 15 min at 2500 rpm. In the first set of experiments, this sample was subjected to pyr-ms analysis. In the second set, the samples were preconcentrated further by SPE. In the SPE experiments, after extraction has been achieved, the disk washed with 10 ml of water and 10 ml of methanol respectively, and finally dried by passing N 2 through the disk.
Two solid probes were used: one a standard heatable probe with a temperature range of 150 -600˚C and other a pyrolysis probe made in this laboratory based on curie point temperature. Quantitative analysis was performed by SIM method at m/z 100. The heating time for standard heatable probe was 3 s and that of pyrolysis probe was less than 1 s. The scan rates of the spectra were 10 scans/s.
CsD was used as an internal standard in HPLC, 1 ml blood and 100 µl of internal standard solution (5 µg ml -1 of CsD in methanol). After blood sample preparation, 200 mg of C 18 was washed with 2×5 ml of methanol and 2×5 ml of water and then added to the sample slowly. Each sample was recovered with 50% acetonitrile/water.
Results and Discussion
Pyrolytic fragmentation is not a random phenomenon, but a process which can, in principle, be predicted from thermodynamic and kinetic data. It is well known that reaction rates and mechanisms change with pyrolysis temperature. 18 In order to find the best pyrolysis temperature, we examined several temperatures in the range of 150 -600˚C, employing the heatable solid probe of MS. The results showed that the mass spectra were reproducible over the temperature range of 400 -450˚C. We believed that, while the peptide bonds (CO-N) dissociate in this range, random dissociation occurs at other temperatures. Thus all experiments with heatable solid probe were carried out at 420˚C. A series of experiments were also performed with the pyrolysis probe mentioned in the experimental section. Although the pyrolysis probe heating time is considerably shorter than that of standard heatable probe (about 1 versus 3 s), there were not very significant differences in the results. Thus only the results of the normal standard heatable probe are presented here. Figure 2 shows total ion current (TIC) pyr-ms of CsA and 3-nitroaniline (internal standard). The first peak belongs to the internal standard and the second is due to the CsA. exist in CsA structure (Fig. 1) . The peak at 100 m/z in Fig. 3 , which is related to MeLeu fragment 14, 16 , shows a good abundance and proved reproducible and is absent in the pure patient blood (Fig. 4) . Thus this peak was used for the quantitative measurements.
High precision quantitative analysis of natural products by SIM requires the use of internal standards. In HPLC measurements, CsD is usually used as an internal standard for determination of CsA. We could not use this, because CsD has a MeLeu fragment in its mass spectrum. 3-Nitroaniline was used as an internal standard for four reasons: First, this compound has m/z at 138 which does not overlap with any CsA pyrolyzed peaks. Second, it does not have similarity in structure with CsA components, therefore it does not react with CsA peptide chain and blood compounds. Third, it is stable at the temperature range used. Finally the peak at 138 m/z also appears in the negative ion spectra, thus it could be used for the negative ion quantitative measurements, if desired. The LOD was calculated to be 0.7 ng ml -1 and relative standard deviation (RSD) <3%.
In the HPLC method of the determination of CsA, normally the preconcentration is achieved by SPE cartridges. In this work, however, SPE disks were preferred because, in a biological matrix, isolation as well as preconcentration of the drug is possible by disks. By this approach CsA can be preconcentrated on C 18 and the disk can be used as a filter. Furthermore, disks permit application of higher flow rates, shorter extraction time and prevent plugging and channeling which may occur in cartridges. [21] [22] [23] Since most of the published data concerning CsA are based on HPLC measurements, we thought it would be interesting if both methods (HPLC and pyr-ms) were applied to the same set of samples and the results were compared. Kidney patient samples were used for these comparison. The mean value of the pyr-ms results was 323 (RSD=3%) compare with 255 ng ml -1 (RSD=7%) for those from HPLC. The reason from this difference (about 27%) is due to the fact that in the pyr-ms experiments the total concentration of CsA and its metabolites are measured, while in the HPLC experiments only CsA concentration is determined. In fact pyr-ms result should be compared with those obtained from nonspecific methods. Table 1 shows the recommended concentration of CsA and its metabolites in the human blood. 24 The binding of Cs to the red blood cell and plasma proteins depend on the temperature and time; therefore recovery plays an important role for HPLC and kit methods. In contrast, in the case of the pyr-ms the recovery step is not necessary and therefore there is no recovery error in this technique. Pyr-ms method shows a shorter time, higher linearity and good reproducibility compared with the other CsA level measurements (Table 2 ). In addition a mass spectrometer is a sensitive instrument and needs only a low volume of sample to respond (10 µl).
Finally, we conclude that pyr-ms is an effective and reliable method for the pharmacokinetic studies and blood level monitoring of CsA in clinical practice. Heart 800 -1200 Kidney 300 -500 Pancreas 300 -600 Fig. 4 Mass spectrum of patient blood.
